HURA TuHURA Biosciences, Inc./NV

NEUTRAL Impact: 5/10 8-K
Horizon weeks Filed Apr 8, 2026 Processed 2mo ago SEC 0001193125-26-147660
8-K context-dependent: Items 5.02, 8.01
Latest settled — T+20d ⚠ clustered
HURA ▲ +29.59% at T+20d
NEUTRAL call ✓ call won +29.59% · α vs SPY +22.02% · entry $1.96 → $2.54
Next anchor: T+60d in 18d
Last close $2.32 (close Jun 12) · +18.37% from $1.96 entry
Entry anchored
Apr 8, 03:59 PM ET
via Databento tick
T+1d
+15.82%
call +15.82% · α +15.88%
$2.27
settled 2mo ago
T+5d
+51.02%
call +51.02% · α +47.83%
$2.96
settled 2mo ago
T+20d
+29.59%
call +29.59% · α +22.02%
$2.54
settled 6w ago
T+60d
call — · α —
in 18d

Price Chart

Loading chart...

Executive Summary

TuHURA Biosciences completed its acquisition of Kineta and released updated pro forma financials showing a combined net loss of $34.6 million for 2025. The company also approved 2025 bonuses and 5% salary increases for its CEO and CFO.

Actionable Insight

Monitor integration progress of Kineta acquisition and upcoming clinical trial developments, as the combined entity continues to operate at a significant loss despite executive compensation increases.

Key Facts

  • Completed acquisition of Kineta on June 30, 2025, with TuHURA as accounting acquirer
  • Pro forma net loss attributable to common stockholders for 2025 was $34.6 million
  • Weighted average shares outstanding increased to 54.3 million post-merger
  • CEO James Bianco received $490,536 bonus and 5% salary increase to $605,956
  • CFO Dan Dearborn received $163,393 bonus and 5% salary increase to $403,676

Financial Impact

Pro forma net loss of $34.6 million for 2025 with 54.3 million weighted average shares outstanding

net lossweighted average shares outstanding

Risk Factors

  • Continued significant net losses post-acquisition
  • Dilution from increased share count and warrant issuances

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-147660
Document: d131347d8k.htm0001193125-26-147660
Document: 0001193125-26-147660-index-headers.html0001193125-26-147660
Document: 0001193125-26-147660-index.html0001193125-26-147660
Document: 0001193125-26-147660.txt0001193125-26-147660
6 reports for HURA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HURA — sortable, filterable
Type Now
May 29, 2026
16d ago
8-K
NEUTRAL ★ 4/10
$2.24 $1.97▼ −12.28%▼ −9.53%$2.32 (+3.57%)
May 15, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$2.55 $2.45▼ −3.92%▼ −5.54%$2.32 (−9.02%)
Apr 22, 2026
7w ago
8-K
MIXED ★ 7/10
$2.68 $2.15▼ −19.96%▼ −20.02%$2.32 (−13.43%)
Apr 8, 2026
9w ago
424B5
BEARISH ★ 7/10
$1.96 $2.96▼ −51.02%▼ −47.83%$2.32 (−18.37%)
Apr 8, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$1.96 $2.96▲ +51.02%▲ +47.83%$2.32 (+18.37%)
Apr 1, 2026
10w ago
8-K
BEARISH ★ 7/10
$1.62 $1.96▼ −20.99%▼ −17.22%$2.32 (−43.21%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 4h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access